Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells-Reference-Cited by-同舟云学术

Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells

Published:2014-08-06 Issue:3 Volume:47 Page:943-951
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Gagliano Teresa,Gentilin Erica,Benfini Katiuscia,Di Pasquale Carmelina,Tassinari Martina,Falletta Simona,Feo Carlo,Tagliati Federico,Uberti Ettore degli,Zatelli Maria Chiara

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-014-0374-z.pdf

Reference41 articles.

1. M. Terzolo, F. Daffara, A. Ardito, B. Zaggia, V. Basile, L. Ferrari, A. Berruti, Management of adrenal cancer: a 2013 update. J. Endocrinol. Invest. 37, 207–217 (2014)

2. M. Fassnacht, M. Kroiss, B. Allolio, Update in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 98, 4551–4564 (2013)

3. M. Terzolo, A. Angeli, M. Fassnacht, F. Daffara, L. Tauchmanova, P.A. Conton, R. Rossetto, L. Buci, P. Sperone, E. Grossrubatscher, G. Reimondo, E. Bollito, M. Papotti, W. Saeger, S. Hahner, A.C. Koschker, E. Arvat, B. Ambrosi, P. Loli, G. Lombardi, M. Mannelli, P. Bruzzi, F. Mantero, B. Allolio, L. Dogliotti, A. Berruti, Adjuvant mitotane treatment for adrenocortical carcinoma. N. Engl. J. Med. 356, 2372–2380 (2007)

4. S.D. Flynn, J.R. Murren, W.M. Kirby, J. Honig, L. Kann, B.K. Kinder, P-glycoprotein expression and multidrug resistance in adrenocortical carcinoma. Surgery. 112, 981–986 (1992)

5. F.J. Sharom, ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics. 9, 105–127 (2008)

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Change of treatment modality and outcomes of adrenocortical carcinoma: a retrospective review of single tertiary center experience over 24 years;Gland Surgery;2022-10

2. Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action;Frontiers in Oncology;2022-07-29

3. How close are we to personalized mitotane dosing in the treatment of adrenocortical carcinoma? State of the art and future perspectives;Expert Opinion on Drug Metabolism & Toxicology;2021-05-04

4. Efflux transporters in cancer resistance: Molecular and functional characterization of P-glycoprotein;Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy;2020

5. In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆;Molecular and Cellular Endocrinology;2019-12